Chartwell Molecules Drug Patent Portfolio
Chartwell Molecules's Family Patents
Recently granted tentative Approvals to Chartwell Molecules
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Chartwell Molecules's portfolio.
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Pramipexole Dihydrochloride | Pramipexole Dihydrochloride |
ORIG-2
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 04 Dec, 2014 |
| Minocycline Hydrochloride | Minocycline Hydrochloride |
ORIG-2
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 30 Nov, 2011 |
| Sumatriptan Succinate | Sumatriptan Succinate |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 27 Aug, 2007 |
Explore deeper patents analysis
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List